RioGin

http://www.riogin.com
Pharma/Therapeutics/Vaccines
Pharma/Therapeutics/Vaccines
  • CEO: Mario Geysen
  • Size of Facility: 2300
  • Company Size: 2
  • Funding Source: Grants (e.g. SBIR, CRCF, CIT)
  • Development Stage:

RioGin is an early stage biotechnology company, based in Charlottesville VA, born from a collaboration between Geysen Enterprises and SRI International. RioGin is dedicated to improving the pharmacokinetic properties of peptide drugs without negatively impacting their pharmacodynamic properties. Using their proprietary platform technology, RioGin is advancing patient quality of life through convenient dosing and reduced side effects resulting in better compliance.